Dr. Gowthami M. Arepally
Overview
Gowthami Arepally is a Hematologist in Durham, North Carolina. Dr. Arepally has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).
Her clinical research consists of co-authoring 76 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
40 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Duke Blood Cancer Center
I have the privilege of caring for patients with various myeloproliferative neoplasms including, polycythemia vera, essential thrombocytosis, primary myelofibrosis, systemic mastocytosis, and chronic myeloid leukemia. My goal is to provide the best possible care for each individual patient in an era where the number of therapeutic options for patients with myeloproliferative neoplasms is rapidly expanding. As a clinical investigator leading several clinical studies in both early and late stages of development, I strive to offer patients access to investigational agents with novel mechanisms of action via participation in clinical trials. I believe that every patient has a unique diagnosis and personal experience with their cancer. I aim to consider the disease, the patient and individual care goals in partnering with patients to develop and implement personalized treatment plans. Dr. Rein is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Systemic Mastocytosis, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.
University Of North Carolina At Chapel Hill
Brandi Reeves is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Reeves is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Multiple Myeloma, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Reeves is currently accepting new patients.
Murat Arcasoy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Arcasoy is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Arcasoy is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- ThrombocytopeniaDr. Arepally isElite. Learn about Thrombocytopenia.
- Distinguished
- Adult Immune ThrombocytopeniaDr. Arepally isDistinguished. Learn about Adult Immune Thrombocytopenia.
- Immune Thrombocytopenic Purpura (ITP)Dr. Arepally isDistinguished. Learn about Immune Thrombocytopenic Purpura (ITP).
- Sickle Cell DiseaseDr. Arepally isDistinguished. Learn about Sickle Cell Disease.
- Advanced
- Acquired HemophiliaDr. Arepally isAdvanced. Learn about Acquired Hemophilia.
- AnemiaDr. Arepally isAdvanced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Arepally isAdvanced. Learn about Antiphospholipid Syndrome.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Autoimmune Hemolytic AnemiaDr. Arepally isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- D-Plus Hemolytic Uremic SyndromeDr. Arepally isAdvanced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Experienced
- Acute Eosinophilic PneumoniaDr. Arepally isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with MaturationDr. Arepally isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Arepally isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Arepally isExperienced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Arepally isExperienced. Learn about Alpha Thalassemia.